These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10685655)

  • 1. Interleukin-2 in the treatment of hematologic malignancies.
    Fefer A
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S31-2. PubMed ID: 10685655
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy with recombinant human interleukin 2 in patients with hematological malignancies after bone marrow or peripheral blood stem cell transplantation.
    Frydecka I; Kosmaczewska A; Boćko D; Ciszak L; Kaczmarek P
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):223-7. PubMed ID: 10483870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fungal infection in hematopoietic stem cell transplantation].
    Taniguchi S
    Rinsho Ketsueki; 2008 Oct; 49(10):1349-57. PubMed ID: 18833919
    [No Abstract]   [Full Text] [Related]  

  • 4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 in the treatment of hematologic malignancies.
    Fefer A
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S35-6. PubMed ID: 9457391
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of natalizumab in hematopoietic stem cell mobilization.
    Neumann F; Zohren F; Haas R
    Expert Opin Biol Ther; 2009 Aug; 9(8):1099-106. PubMed ID: 19566481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell transplantation in hematologic malignancy.
    Archuleta TD; Devetten MP; Armitage JO
    Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of interleukin-2--based immunotherapy in hematological malignancies].
    Ackerstein A; Toren A; Slavin S; Nagler A
    Harefuah; 1996 May; 130(9):613-7. PubMed ID: 8794642
    [No Abstract]   [Full Text] [Related]  

  • 9. Third biannual report of the Cochrane Haematological Malignancies Group.
    Kober T; Skoetz N; Trelle S; Bohlius J; Engert A;
    J Natl Cancer Inst; 2005 Aug; 97(16):E2. PubMed ID: 16106014
    [No Abstract]   [Full Text] [Related]  

  • 10. Manipulation of the stem cell as a target for hematologic malignancies.
    Ballen KK; Becker PS; Stewart FM; Quesenberry PJ
    Semin Oncol; 2000 Oct; 27(5):512-23. PubMed ID: 11049019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions.
    Nadal E; Fowler A; Kanfer E; Apperley J; Goldman J; Dazzi F
    Exp Hematol; 2004 Feb; 32(2):218-23. PubMed ID: 15102484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on non-myeloablative stem cell transplantation for hematologic malignancies.
    Giralt S
    Int J Hematol; 2002 Aug; 76 Suppl 1():368-75. PubMed ID: 12430884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trials for hematopoietic stem cell transplantation: lessons to be learned from the European experience.
    Kuthiala SS; Lyman GH; Ballester OF
    Bone Marrow Transplant; 2006 Jan; 37(2):219-21. PubMed ID: 16299544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation.
    Wolff SN
    Bone Marrow Transplant; 2002 Apr; 29(7):545-52. PubMed ID: 11979301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies.
    Niscola P; Romani C; Scaramucci L; Dentamaro T; Cupelli L; Tendas A; Piccioni D; Giovannini M; Tolu B; Cartoni C; Arcuri E; Perrotti A; Palumbo R; de Fabritiis P
    Bone Marrow Transplant; 2008 May; 41(9):757-64. PubMed ID: 18246112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies.
    Handgretinger R; Kurtzberg J; Egeler RM
    Pediatr Clin North Am; 2008 Feb; 55(1):71-96, x. PubMed ID: 18242316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy with interleukin-2 after hematopoietic cell transplantation for hematologic malignancy.
    Margolin K; Forman SJ
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S33-8. PubMed ID: 10685656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: an update.
    Vigorito AC; Marques Júnior JF; Aranha FJ; Oliveira GB; Miranda EC; De Souza CA
    Haematologica; 2001 Jun; 86(6):665-6. PubMed ID: 11418381
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nonmyeloablative stem cell transplantation as cancer immunotherapy].
    Willems E; Baron F; Vanstraelen G; Frère P; Fillet G; Beguin Y
    Rev Med Suisse; 2005 Aug; 1(30):1973-7. PubMed ID: 16200942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
    Dey BR; McAfee S; Sackstein R; Colby C; Saidman S; Weymouth D; Poliquin C; Vanderklish J; Sachs DH; Sykes M; Spitzer TR
    Biol Blood Marrow Transplant; 2001; 7(11):604-12. PubMed ID: 11760148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.